Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PembroHeme: Keytruda with Chemotherapy in Advanced Lymphoma
NCT02408042Phase 2Withdrawn
- Sponsor
- Western Regional Medical Center
- Start
- Apr 2015
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
Phase 2, open-label trial of pembrolizumab in Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), sponsored by Western Regional Medical Center. Planned start Apr 2015; status: withdrawn.
02
Drugs
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT02408042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408042.